Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OPSUMIT for Cor pulmonale chronic: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 21 adverse event reports in the FDA FAERS database where OPSUMIT was used for Cor pulmonale chronic.

Most Reported Side Effects for OPSUMIT

Side Effect Reports % Deaths Hosp.
Dyspnoea 52 15.3% 5 24
Headache 33 9.7% 1 2
Death 27 8.0% 27 6
Nausea 21 6.2% 2 4
Cough 19 5.6% 1 5
Fluid retention 19 5.6% 2 9
Malaise 19 5.6% 0 6
Nasal congestion 19 5.6% 0 2
Pneumonia 19 5.6% 9 15
Oedema peripheral 17 5.0% 0 7
Pulmonary arterial hypertension 16 4.7% 10 10
Disease progression 14 4.1% 13 8
Fatigue 13 3.8% 0 5
Fluid overload 13 3.8% 4 12
Oedema 13 3.8% 1 6

Other Indications for OPSUMIT

Pulmonary arterial hypertension (176) Product used for unknown indication (73) Pulmonary hypertension (41) Connective tissue disorder (7) Cardiac disorder (6) Portopulmonary hypertension (6)

Other Drugs Used for Cor pulmonale chronic

TREPROSTINIL (1,407) AMBRISENTAN (879) MACITENTAN (254) EPOPROSTENOL (239) BOSENTAN\BOSENTAN (238) REMODULIN (220) TYVASO (143) TRACLEER (101) ILOPROST (65) BOSENTAN (60)

Related Pages

OPSUMIT Full Profile All Cor pulmonale chronic Drugs OPSUMIT Demographics OPSUMIT Timeline